print   Bookmark and Share  |  RSS  |  A  A  A

WINSHIP CANCER INSTITUTE IN THE NEWS

April 15, 2014
Grant W. Carlson, MD, professor of surgery, Emory University School of Medicine, chief, Division of Plastic Surgery, Emory University Hospital, discusses treating younger patients with breast cancer.
 
Oncology Issues, The Journal of the Association of Community Cancer Centers, Ask ACCC's Community Resource Centers
March/April 2014
Targeted therapy drugs have revolutionized the treatment of chronic myeloid leukemia (CML), allowing many patients to live normal life spans, but successful treatment depends on consistent monitoring and management of the disease and side effects. Winship's s Dr. H. Jean Khoury explains how an outpatient coordinated team approach developed by Winship accomplishes this in the "Ask ACCC's Community Resource Centers" feature.
 
April 8, 2014
Winship's Dr. Suresh Ramalingam commented on a new study in the Journal of the American Medical Association that shows traditional chemotherapy outperforms newer, targeted treatments in some lung cancer patients.
 
Georgia Trend, Help and Hope
April 2014 issue
Winship Cancer Institute executive director, Dr. Walter J. Curran Jr. is quoted in article about childhood cancer and how Georgia is leading the charge for a cure.
 
 
March 11, 2014
A recent study conducted by the fine folks at the Emory Winship Cancer Institute claims only 5% of the men questioned were aware of the prostate's purpose...Dr. Viraj Master, who helped lead the study, says men are so uninformed about simple prostate-related terminology that it could limit the ability of these patients to make wise decisions about their health. 
 
Congressionally Directed Medical Research Programs, Predicting Prostate Cancer Recurrence - Using Biomarkers to Guide Treatment Decision Making
March 11, 2014
With funding from an FY09 PCRP Idea Development Award, Dr. Carlos S. Moreno, at Emory University, has identified and validated biomarkers that can help to predict the likelihood of prostate cancer recurrence after surgery.

The Atlanta Journal Constitution, Clinical trials seek greater diversity
March 7, 2014
Multiple myeloma affects African-Americans at a much higher rate than whites. In her trial, researchers at the Winship Cancer Institute at Emory University tested what was then a new drug, pomalidomide, in combination with an already-approved one. Her outcome was favorable. Read full article here (PDF).

Macon's The Telegraph, 'Radiation Vacations' a Way for Macon Family to Pay It Forward
March 4, 2014
Radiation Vacation also stocks a “treasure box” at the Winship Cancer Institute at Emory, filled with coloring books, doodle pads and puzzles. About 260 children (ages birth to 21 years) receive radiation treatments at the facility every year. 

The Cancer Letter, Groups Have No Budgets As NCTN Begins Work March 1
February 28, 2014
Two years ago, NCI officials made a promise to increase the budget of the cooperative groups program by $25.6 million. The boost, which was approved by the NCI Board of Scientific Advisors, was part of an effort to revamp the groups inspired by a report from the Institute of Medicine. On March 1, as the cooperative group program officially becomes the NCI National Clinical Trials Network, new money will not be a part of the transformation. (Winship executive director, Dr. Walter J. Curran Jr. is quoted.) Read full article here (PDF).

HemOnc Today, Targeted Therapies May Be 'Game Changer' for CLL Treatment
February 25, 2014
Winship Cancer Institute hematologist, Jonathon B. Cohen, MD, MS, weighs in on debate over targeted therapies in CLL treatment.

February 20, 2014
A newly published study in the New England Journal of Medicine shows that overall survival is not improved for certain brain tumor patients who receive the drug bevacizumab as a first-line treatment. Dr. Walter J. Curran, Jr., executive director of the Winship Cancer Institute of Emory University, is a co-author of the study conducted by the Radiation Therapy Oncology Group.
 
February 18, 2014
Winship Executive Director Walter J. Curran Jr., MD is the senior author of a newly published study by the Radiation Therapy Oncology Group (RTOG) in the Journal of Clinical Oncology that looks at a specific gene mutation in patients with high-grade glioma. Those treated with chemo-radiotherapy versus radiotherapy alone were shown to live longer. Curran is also group chairman of RTOG.
 
Atlanta Business Chronicle, Emory studying anti-cancer effects of soy
February 7, 2014
Soy has the ability to reduce heart disease risk, reduce cholesterol and be made into replacements for dairy and meat. But two researchers at Emory University believe its benefits may extend far beyond that, and are preparing to do clinical trials to test its efficacy in treating prostate cancer, as well as the long-term side effects of radiation suffered by those with certain head and neck cancers. Read full article here (PDF).
 
CNN, Cancer rate jump predicted
February 4, 2014
CNN's Brooke Baldwin talks to Dr. Walter Curran about a World Health Organization report that says cancer rates will rise.
 
January 22, 2014
“As of 5 years ago, I would say that 70% of chemotherapy was given intravenously, but these days it feels more like 50/50 [between oral and intravenous drugs],” says R. Donald Harvey, PharmD, assistant professor of hematology/oncology at the Emory University School of Medicine in Atlanta, Georgia. “Of the drugs that are in the pipeline, about 30% are oral. We will see more and more oral drugs, and we may see a combination of the 2 to treat certain cancers.”
 
January 13, 2014
Researchers at the Winship Cancer Institute at Emory University believe they have uncovered a tool that appears to fight cancer cells..."Cancer cells cannot grow when you have this kind of agent come into their system," says Dr. Dong Shin, with Emory.
 
CNN, What is a clinical trial?
January 10, 2014
CNN Accent Health profiles Holly Johnston, a patient in the phase 1 clinical trials program at Winship Cancer Institute of Emory University. Director of Phase I Clinical Trials at Winship, Dr. Donald Harvey describes in this story how patients are eligible to participate in a clinical trial.
 
December 25, 2013
For 75 years, metro Atlantans have come to the Winship Cancer Institute at Emory University for the prevention and treatment of cancer. And right in the lobby, they can occasionally find a man who is fighting through his own struggle. Bruce Gilbert is a 63-year-old, once-a-week volunteer who plays the piano in the Winship lobby.
 
December 18, 2013
Just ask the 24 blood cancer patients spending the holidays in the Winship Cancer Institute's Bone Marrow Transplant Unit at Emory Hospital, where Drea Fels is a nurse. "What our patients are going through is cancer that specifically lies in their bone marrow," Fels said. "So what we have to do is completely clean out their bone marrow, which includes their  immune system, and take it away.  We do that with chemo."
 
December 4, 2013
The executive director of Emory University's Winship Cancer Institute, Dr. Walter Curran, says sequestration is taking its toll on the institute. Curran made the comments during a teleconference Tuesday with the American Cancer Society Action Network and other cancer center directors.
 
December 4, 2013
Dr. Walter J. Curran, executive director of the Winship Cancer Institute of Emory University, Atlanta, said that the center will have $5 million less from March 2013 to March 2014. With potentially another 5% cut in the NIH budget due next year, Winship is looking at another $4 million reduction for 2014, he said.
 
October 20, 2013
At Emory's Winship Cancer Institute, ultrasound technician Tricia Harper is the person you see when there's a red flag on your breast x-ray. Winship radiologist Dr. Carl D'orsi said those call backs for more mammograms or a breast ultrasound happen more often than you'd think.
 
October 20, 2013
Oncology Nutrition Specialist Tiffany Barrett discusses the importance of nutrition for breast cancer survivors.
 
October 5, 2013
More than 3,000 people ran Saturday morning to help fight cancer. The third-annual Winship Win the Fight 5K kicked off this morning at Emory University's McDonough Field in Druid Hills. Participants raised more than $445,000 for cancer research.
 
September 16, 2013
Hair loss is one of the most visible -- and most hated -- signs of breast cancer. One Atlanta woman thinks she may have found a way to hang on to the hair she loves
 
Atlanta Business Chronicle, Winship's Curran named GRA Eminent Scholar
September 11, 2013
Winship Cancer Institute’s Dr. Walter J. Curran Jr. has been named a Georgia Research Alliance Eminent Scholar and Chair in Cancer Research.
 
September 9, 2013
Knowledge is good. Knowledge is very good. Not so long ago, I didn't know nothing about no prostate cancer. Before my father was diagnosed with this snippy little disease, I couldn't tell you the function of the prostate. I never thought about it, and I wasn't alone. A recent study conducted by the fine folks at the Emory Winship Cancer Institute claims only 5% of the men questioned were aware of the prostate's purpose.
 
September 5, 2013
An Emory radiologist has received a $1 million grant to study how much radiation is delivered to the glandular tissue in a person’s breast during an imaging test.
 
April 17, 2013
When you think of a cancer center, dogs probably aren't the first thing that comes to mind.  But at the Winship Cancer Institute at Emory University, dogs sometimes roam the halls visiting patients and families who need a little TLC.